(Q36422578)

14 August 2017

1 reference

title

Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers (English)

1 reference

14 August 2017

Cellular processes in atherogenesis: Potential targets of Ca2+ channel blockers (English)

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Cardiology and cardiovascular medicine

22 October 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

22 October 2022

author name string

G. Schmitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654052

22 October 2022

J. Hankowitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654052

22 October 2022

E. M. Kovacs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1654052

22 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1654052

22 October 2022

publication date

1 June 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:002191509190074D?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

https://api.elsevier.com/content/article/PII:002191509190074D?httpAccept=text/plain

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

22 October 2022

1 reference

14 August 2017

88

1 reference

14 August 2017

2-3

1 reference

14 August 2017

109-132

1 reference

The pathogenesis of atherosclerosis--an update

14 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Growth factors and the pathogenesis of atherosclerosis

22 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation

22 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.

22 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

22 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

The problems and the promise of prostaglandin influences in atherogenesis

22 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

22 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries

22 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Regulation of P2y-purinoceptor-mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration

22 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms

22 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells

22 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

22 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Procoagulant activity expression by macrophages from atheromatous vascular plaques

22 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.

22 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Increased superoxide anion release from human endothelial cells in response to cytokines

22 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

22 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of nifedipine (Adalat) on platelet function in vitro and in vivo

22 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Calcium blocker diltiazem inhibits platelet activation and stimulates vascular prostacyclin synthesis

22 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of verapamil on platelet aggregation, ATP release and thromboxane generation

22 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effect of nicardipine on angiotensin II platelet content

22 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells

22 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Densitometric measurement of increased endothelial permeability in arteriosclerotic plaques and inhibition of permeability under the influence of two calcium antagonists

22 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Ca2+ antagonists and vascular disease

22 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Differential effects of non-specific beta-blockade and calcium antagonism on blood-clotting mechanisms

22 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise

22 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists

22 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Direct evidence for intracellular divalent cation redistribution associated with platelet shape change

22 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion

22 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Calcium ions, drug action and platelet function

22 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Low density lipoprotein undergoes oxidative modification in vivo

22 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Atherosclerosis. Scavenging for receptors

22 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

22 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Role of triglyceride-rich lipoproteins in progression of atherosclerosis

22 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Lymphokines secreted by an established lymphocyte line modulate receptor-mediated endocytosis in macrophages derived from human monocytes

22 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages

22 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of activation on lipid and lipoprotein metabolism in murine macrophages

22 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Lipids and lymphocyte function

22 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Platelets stimulate aortic smooth muscle cell migration in vitro. Involvement of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid

22 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine

22 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Nisoldepine inhibits formyl-methionyl-leucyl-phenylalanine (fMet-Leu-Phe) receptor-coupled calcium transport in human neutrophils

22 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Adhesion receptors of the immune system

22 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.

22 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect

22 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue

22 October 2022

74

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Enhancement of cholesteryl ester metabolism in cultured human monocyte-derived macrophages by verapamil

22 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.

22 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2

22 October 2022

78

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblasts.

22 October 2022

79

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells

22 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effect of verapamil on cholesteryl ester hydrolysis and reesterification in macrophages

22 October 2022

81

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Calcium antagonists and low density lipoprotein receptors

22 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Endothelial cell influences on vascular smooth muscle phenotype

22 October 2022

83

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells

22 October 2022

84

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues

22 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture

22 October 2022

86

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Chemotaxis of monocytes and neutrophils to platelet-derived growth factor

22 October 2022

87

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Platelet-derived growth factor: three isoforms and two receptor types

22 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Regulation of the mevalonate pathway

22 October 2022

90

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

22 October 2022

93

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Vasoactive effects of growth factors

22 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells

22 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor

22 October 2022

99

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation

22 October 2022

101

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromas.

22 October 2022

102

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery

22 October 2022

105

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

The effect of calcium antagonists on intimal cell proliferation in atherogenesis

22 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size

22 October 2022

109

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of nitrendipine on growth activity in cultured vascular smooth muscle cells

22 October 2022

110

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Mechanism of antiatherogenic action of calcium antagonists

22 October 2022

111

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Inhibition of radioligand binding to A1 adenosine receptors by Bay K8644 and nifedipine

22 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effect of elastin peptides on human monocytes: Ca2+ mobilization, stimulation of respiratory burst and enzyme secretion

22 October 2022

113

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta

22 October 2022

114

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Cell biology of arterial proteoglycans.

22 October 2022

115

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of the Calcium Antagonist Verapamil onin VitroSynthesis of Skeletal Collagen and Noncollagen Protein*

22 October 2022

117

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Antiatherogenic properties of calcium antagonists

22 October 2022

118

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Action of calcium channel and beta-adrenergic blocking agents in bilayer lipid membranes

22 October 2022

119

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

The influence of calcium channel blockers on superoxide anions

22 October 2022

120

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadine

22 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors

22 October 2022

122

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists

22 October 2022

124

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation

22 October 2022

125

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Nonlinear charge movement in mammalian cardiac ventricular cells. Components from Na and Ca channel gating

22 October 2022

126

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Effects of sphingomyelin degradation on cell cholesterol oxidizability and steady-state distribution between the cell surface and the cell interior

22 October 2022

128

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Cellular calcium and atherosclerosis: a brief review

22 October 2022

129

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle

22 October 2022

130

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Generation of calcium oscillations in fibroblasts by positive feedback between calcium and IP3.

22 October 2022

132

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Receptor-effector coupling by G proteins

22 October 2022

133

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Purified calcium channels have three allosterically coupled drug receptors

22 October 2022

135

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites

22 October 2022

136

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Characterization of adenosine receptors in isolated cerebral arteries of cat

22 October 2022

140

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization

22 October 2022

143

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Characterization of the human T lymphocyte adenosine receptor: comparison of normal and systemic lupus erythematosus cells

22 October 2022

145

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Peripheral type benzodiazepine receptors

22 October 2022

147

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sites

22 October 2022

149

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Interactions of lipids with peripheral-type benzodiazepine receptors

22 October 2022

150

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction

22 October 2022

152

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine

22 October 2022

153

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90074-D

22 October 2022

Identifiers

1 reference

14 August 2017

1 reference